Jpmorgan Chase & CO Siga Technologies Inc Transaction History

Jpmorgan Chase & CO

  • $1.14 Trillion
  • Q2 2024

A detailed history of Jpmorgan Chase & CO transactions in Siga Technologies Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 27,630 shares of SIGA stock, worth $192,304. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,630
Previous 33,941 18.59%
Holding current value
$192,304
Previous $290,000 27.93%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
SELL
$6.32 - $10.46 $39,885 - $66,013
-6,311 Reduced 18.59%
27,630 $209,000
Q1 2024

May 10, 2024
SELL
$4.51 - $8.92 $46,890 - $92,741
-10,397 Reduced 23.45%
33,941 $290,000
Q4 2023

Feb 12, 2024
SELL
$4.82 - $6.25 $4,391 - $5,693
-911 Reduced 2.01%
44,338 $248,000
Q3 2023

Nov 14, 2023
BUY
$4.32 - $5.77 $28,589 - $38,185
6,618 Added 17.13%
45,249 $237,000
Q2 2023

Aug 11, 2023
SELL
$5.0 - $6.31 $1,445 - $1,823
-289 Reduced 0.74%
38,631 $195,000
Q1 2023

May 18, 2023
BUY
$5.23 - $8.42 $188,719 - $303,827
36,084 Added 1272.36%
38,920 $223,000
Q1 2023

May 11, 2023
SELL
$5.23 - $8.42 $278,565 - $448,474
-53,263 Reduced 94.94%
2,836 $16,000
Q4 2022

Feb 13, 2023
BUY
$7.29 - $10.14 $38,075 - $52,961
5,223 Added 10.27%
56,099 $413,000
Q3 2022

Nov 14, 2022
BUY
$10.02 - $26.15 $121,452 - $316,964
12,121 Added 31.28%
50,876 $524,000
Q2 2022

Aug 11, 2022
BUY
$6.5 - $13.68 $33,709 - $70,944
5,186 Added 15.45%
38,755 $449,000
Q1 2022

May 11, 2022
SELL
$5.96 - $7.61 $176,296 - $225,103
-29,580 Reduced 46.84%
33,569 $237,000
Q4 2021

Feb 10, 2022
BUY
$6.96 - $9.26 $248,666 - $330,841
35,728 Added 130.29%
63,149 $476,000
Q3 2021

Nov 12, 2021
BUY
$5.71 - $7.39 $156,573 - $202,641
27,421 New
27,421 $203,000

Others Institutions Holding SIGA

# of Institutions
166
Shares Held
33.8M
Call Options Held
353K
Put Options Held
853K
View Full List

About SIGA TECHNOLOGIES INC

SIGA Quotes by TradingView
  • Ticker SIGA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 73,024,096
  • Market Cap $508M
  • Description
  • SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...
More about SIGA
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email